ut-logo website  
 
Log in
Express registration and login!
If you have a Facebook or LinkedIN account, use one of the buttons on the left to either login or create a new account.

Log in

 

You are here: Home Conferences Conferences DGU 2011 Session Highlights
Bladder Cancer Highlights

Bladder Cancer Highlights

DGU 2011 - Phase-III trial to compare adjuvant versus progression-dependent chemotherapy of locally advanced urothelial cancer of the bladder following cystectomy: Gemcitabine monotherapy in patients not suitable for cisplatinum (AUO-trial AB 22/00) - Ses

  • Print
HAMBURG, GERMANY (UroToday.com) - In this trial, 120 patients with locally advanced urothelial cancer of the bladder not suitable for cisplatinum-based chemotherapy were randomized to receive adjuvant monotherapy with gemcitabine (arm A) or progression-triggered gemcitabine (arm B).

Read more...

DGU 2011 - Prospective, randomized, double-blind, multicenter phase-II trial comparing gemcitabine/cisplatinum +/- sorafenib in locally advanced or metastatic urothelial cancer of the bladder (AUO-trial AB 31/05) - Session Highlights

  • Print
HAMBURG, GERMANY (UroToday.com) - In this trial, the addition of sorafenib (versus placebo) to first-line therapy with gemcitabine/cisplatinum (gem/cis) in patients with locally advanced or metastatic urothelial cancer of the bladder was tested.

Read more...

DGU 2011 - Prospective long-term trial “UroScreen” for the early diagnosis of urothelial cancer of the bladder in a risk cohort of patient using urine-based tests - Session Highlights

  • Print
HAMBURG, GERMANY (UroToday.com) - UroScreen is a prospective trial in 1,772 chemical workers who were exposed to aromatic amines in the past.

Read more...